Observational studySupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
Integrative oncology consultation and patient referral to complementary therapies: results from the prospective study THERAC.
Observational study in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFollowing cancer diagnosis, patients regularly request further information regarding alternative complementary therapies besides conventional treatments to better manage treatment-related side effects, improve their quality of life and prolong survival. Many patients turn to integrative medicine approaches and lifestyle changes. A more transparent framework would be required to provide appropriate management, ensure quality control, and limit potential abuses. This study reported real-life data collected during integrative oncology (IO) consultation implemented in a comprehensive cancer center.
methodsThis observational, descriptive study used prospective data collected using clinician-rated assessments during IO consultation at inclusion (T0), 3 months (T1), and 6 months (T2) after inclusion.
resultsAmong the 50 patients attending an IO consultation at the Léon Bérard Cancer Center, majority were women (n = 45; 90%) with breast cancer (n = 28; 56%), mainly from the wealthy metropolitan areas (n = 22; 44%). Most of them had a first IO consultation duration lasting 60 min (n = 40; 82%), including aromatherapy prescription (n = 35; 74%) and an orientation to supportive care (i.e., psychological support (n = 24; 69%), adapted physical activities (n = 22; 63%). Patients mostly expressed a request for a comprehensive support (n = 37; 74%), improvement in their well-being (n = 34; 68%), or reduction in treatment side effects (n = 33; 66%). At 3 and 6 months, almost all patients were satisfied with the IO consultation (respectively, n = 27/29; 93%, n = 11/11; 100%).
conclusionPatients who attended an IO consultation had specific sociodemographic characteristics. The IO consultation contributed to identify supportive care needs and to guide referral to qualified professionals. Referral to complementary therapy (CTh) depended on institutional resources and on the city-hospital network.
Indexed as
Identifiers
42736369What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.